Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.02 - Poster Session 1 - Novel Cancer Genes and Pathways

    • Type: Poster Session
    • Track: Biology
    • Presentations: 22
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.02-018 - the wnt signaling pathway in lung carcinoid

      09:30 - 09:30  |  Author(s): R. Garcia Campelo

      • Abstract

      Loading...

  • +

    P1.07 - Poster Session 1 - Surgery

    • Type: Poster Session
    • Track: Surgery
    • Presentations: 48
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.07-046 - clinical and pathological profile of lung carcinoid

      09:30 - 09:30  |  Author(s): T. Hermida

      • Abstract

      Loading...

  • +

    P2.02 - Poster Session 2 - Novel Cancer Genes and Pathways

    • Type: Poster Session
    • Track: Biology
    • Presentations: 21
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.02-017 - analysis of p53, Rb, c-met, c-kit and PDGF/ in lung carcinoids

      14:02 - 14:19  |  Author(s): G. Alonso

      • Abstract

      Loading...

    • +

      P2.02-018 - the notch/hes1/ascl1 signaling pathway in lung carcinoid

      14:19 - 14:36  |  Author(s): R. Garcia Campelo

      • Abstract

      Loading...

    • +

      P2.02-019 - analysis of p53, Rb, c-met, c-kit and PDGFα/β in lung carcinoids.

      14:36 - 14:53  |  Author(s): R. Garcia Campelo

      • Abstract

      Loading...

  • +

    P2.11 - Poster Session 2 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 46
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.11-044 - Phase IB study to evaluate the efficacy and tolerability of Olaparib (AZD2281) plus Gefitinib in patients (P) with Epidermal Growth Factor Receptor (EGFR) mutation positive advanced Non-Small Cell Lung Cancer (NSCLC) patients (P). (NCT=1513174/GECP-GOAL)

      09:30 - 09:30  |  Author(s): R. Garcia Campelo

      • Abstract

      Loading...